Long COVID Paper Under Scrutiny; Outage at 988; Al Roker's Clot Complications

— Health news and commentary from around the Web gathered by MedPage Today staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require subscriptions.

The Lancet issued an expression of concern while it investigates "data errors" in a widely reported long COVID paper. (Retraction Watch)

Teen brains aged faster during the pandemic due to stress. (Biological Psychiatry)

CDC research showed that almost half of U.S. adults with COVID-19 antibodies were unaware they had been infected with the virus.

Experts say the CDC's work-from-home policies may hinder plans for agency-wide reform. (CNN)

In Philadelphia, "tranq" in the drug supply is leaving users with horrific wounds. (STAT)

In a preliminary study involving healthy volunteers, a vaccine candidate to prevent HIV induced a strong immune response, a key first step in demonstrating effectiveness. (CNN)

A federal claims court ruled in favor of Gilead Sciences in an ongoing patent dispute with the CDC over development of the combination drug emtricitabine/tenofovir (Truvada) for HIV pre-exposure prophylaxis. (Endpoint News)

A novel, and probably unexpected, use for dating apps: Tracking down contacts exposed to sexually transmitted infections. (Kaiser Health News)

A widespread outage shut down the new 988 suicide lifeline for several hours on Thursday. (AP)

Without congressional resuscitation, the pandemic-driven Acute Hospital Care at Home program -- which demonstrated the feasibility of providing hospital-level care at home -- could come to a close at the end of the year. (Axios)

Scynexis announced FDA approval of the non-azole antifungal ibrexafungerp (Brexafemme) to prevent recurrent vulvovaginal candidiasis, in addition to the existing indication for treatment of the infection.

Meanwhile, Y-mAbs Therapeutics said the FDA rejected omburtamab for metastatic neuroblastoma, with the agency recommending further clinical trials to demonstrate efficacy. The action follows a unanimous vote against approval by the Oncologic Drugs Advisory Committee.

Testimony in the nation's first trial about gender-affirming care wrapped up in Little Rock, Arkansas, with an endocrinologist who has spoken against the care for minors. (AP)

How do poorly staffed nursing homes get away with it? (USA Today)

The TODAY show's Al Roker returned to the hospital for treatment of complications of a clotting disorder. (NBC News)

In a letter to HHS Secretary Xavier Becerra and FDA commissioner Robert Califf, MD, a bipartisan group of senators expressed "strong concern" about the ongoing shortage of amoxicillin and encouraged a more forceful effort to address the problem. (Endpoint News)

Speaking of shortages, infant formula will likely be tougher to find into the spring of 2023, according to the maker of the best-selling brand on the market. (Reuters)

Former NBA star Jeremy Lin, currently playing for a pro basketball team in China, was fined approximately 10,000 yuan (~$1,400) for criticizing anti-COVID quarantine facilities. (AP)

Meanwhile, the country pledges that it will slowly exit its "zero COVID" policies. (Washington Post)

Parents of a former Stanford soccer star allege the school's "overly punitive" discipline led to her suicide. (Washington Post)

Four Navy sailors died by suicide within weeks of being assigned to the same facility. (NBC News)

A Florida sheriff blamed behavioral problems in the county's schools on the demise of corporal punishment resulting in kids who no longer fear having "the cheeks of their ass torn off." (Vice)

An artificial intelligence-aided analysis of COVID-associated symptoms identified four distinct phenotypes of long COVID: cardiac and renal; respiratory, sleep, and anxiety; musculoskeletal and nervous system; and digestive and respiratory system. (Nature Medicine)

Holiday stress disrupting your sleep and leaving you feeling a little prickly? Here's what to do about it. (CNN)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow